Qualigen Therapeutics Inc (QLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,175 | 402 | 3,166 | 17,538 | N/A |
| Receivables | N/A | N/A | N/A | 822 | N/A |
| Inventories | N/A | N/A | N/A | 1,056 | N/A |
| Other current assets | 2,011 | 0 | 6,288 | 0 | 0 |
| TOTAL | $4,685 | $1,167 | $10,821 | $20,796 | $N/A |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 26 | 204 | N/A |
| Intangibles | 0 | 0 | 0 | 171 | 0 |
| Other Non-Current Assets | 2 | 867 | 8,237 | 1,664 | 0 |
| TOTAL | $2 | $867 | $8,263 | $2,039 | $N/A |
| Total Assets | $4,687 | $2,033 | $19,084 | $22,836 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,299 | 60 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,568 | 2,223 | 620 | 886 | 0 |
| Accrued Expenses | 170 | 560 | 865 | 1,794 | N/A |
| Other current liabilities | 269 | 55 | 3,623 | 1,686 | N/A |
| TOTAL | $2,008 | $4,137 | $8,608 | $4,636 | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 135 | N/A |
| Other Non-Current Liabilities | 0 | 343 | 4,103 | 1,543 | 0 |
| TOTAL | $N/A | $N/A | $1,709 | $1,636 | $N/A |
| Total Liabilities | $2,008 | $4,137 | $10,317 | $6,271 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,635 | 126 | 101 | 71 | 58 |
| Common Shares | 65 | 43 | 42 | 35 | N/A |
| Retained earnings | -123,062 | -116,802 | -103,385 | -84,745 | N/A |
| Other shareholders' equity | 0 | 0 | 1,582 | 0 | 0 |
| TOTAL | $2,679 | $-2,104 | $8,767 | $16,565 | $N/A |
| Total Liabilities And Equity | $4,687 | $2,033 | $19,084 | $22,836 | $0 |